T. Rowe Price Associates’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$51.7M Sell
600,165
-95,794
-14% -$8.6M 0.01% 758
2025
Q4
$60.8M Sell
695,959
-395,773
-36% -$30M 0.01% 752
2025
Q3
$62.5M Buy
1,091,732
+17,066
+2% +$983K 0.01% 729
2025
Q2
$63.4M Sell
1,074,666
-73,713
-6% -$4.76M 0.01% 672
2025
Q1
$84.1M Buy
1,148,379
+25,247
+2% +$2.09M 0.01% 582
2024
Q4
$92.9M Sell
1,123,132
-9,901
-0.9% -$781K 0.01% 577
2024
Q3
$81.1M Sell
1,133,033
-71,632
-6% -$5.06M 0.01% 612
2024
Q2
$82.5M Buy
1,204,665
+53,005
+5% +$3.17M 0.01% 586
2024
Q1
$61.8M Buy
1,151,660
+81,944
+8% +$4.41M 0.01% 668
2023
Q4
$57M Sell
1,069,716
-10,139
-0.9% -$494K 0.01% 668
2023
Q3
$53.6M Buy
1,079,855
+90,295
+9% +$5.05M 0.01% 665
2023
Q2
$58.9M Buy
989,560
+117,451
+13% +$6.69M 0.01% 655
2023
Q1
$49.4M Sell
872,109
-1,792
-0.2% -$115K 0.01% 686
2022
Q4
$64.9M Buy
873,901
+2,143
+0.2% +$146K 0.01% 592
2022
Q3
$51.9M Buy
871,758
+5,267
+0.6% +$317K 0.01% 637
2022
Q2
$48.6M Buy
866,491
+5,224
+0.6% +$343K 0.01% 875
2022
Q1
$63.5M Buy
861,267
+4,029
+0.5% +$280K 0.01% 887
2021
Q4
$61.9M Sell
857,238
-15,755
-2% -$1.14M 0.01% 928
2021
Q3
$66.9M Sell
872,993
-3,988
-0.5% -$320K 0.01% 909
2021
Q2
$68M Buy
876,981
+13,663
+2% +$971K 0.01% 927
2021
Q1
$53.2M Sell
863,318
-15,907
-2% -$1.01M 0.01% 982
2020
Q4
$57.3M Buy
879,225
+13,115
+2% +$754K 0.01% 916
2020
Q3
$42.9M Buy
866,110
+4,364
+0.5% +$225K 0.01% 923
2020
Q2
$41.1M Sell
861,746
-10,884
-1% -$525K 0.01% 914
2020
Q1
$37.1M Buy
872,630
+337
+0% +$16.6K 0.01% 886
2019
Q4
$51.4M Buy
872,293
+38,634
+5% +$2.1M 0.01% 906
2019
Q3
$42.6M Buy
833,659
+46,659
+6% +$2.22M 0.01% 926
2019
Q2
$33.3M Sell
787,000
-388
-0% -$16.8K ﹤0.01% 1017
2019
Q1
$38.9M Buy
787,388
+22,534
+3% +$1.02M 0.01% 966
2018
Q4
$33.1M Buy
764,854
+50,138
+7% +$2.5M 0.01% 971
2018
Q3
$40.6M Buy
714,716
+233,402
+48% +$12.3M 0.01% 995
2018
Q2
$24.3M Buy
481,314
+462,596
+2,471% +$24.1M ﹤0.01% 1143
2018
Q1
$933K Buy
18,718
+135
+0.7% +$6.34K ﹤0.01% 1820
2017
Q4
$764K Sell
18,583
-20
-0.1% -$700 ﹤0.01% 1910
2017
Q3
$553K Hold
18,603
﹤0.01% 2052
2017
Q2
$617K Buy
18,603
+10
+0.1% +$314 ﹤0.01% 1971
2017
Q1
$551K Buy
18,593
+5,313
+40% +$145K ﹤0.01% 2022
2016
Q4
$329K Hold
13,280
﹤0.01% 2219
2016
Q3
$300K Hold
13,280
﹤0.01% 2215
2016
Q2
$316K Hold
13,280
﹤0.01% 2141
2016
Q1
$315K Hold
13,280
﹤0.01% 2134
2015
Q4
$369K Buy
13,280
+3,080
+30% +$77.3K ﹤0.01% 2076
2015
Q3
$211K Hold
10,200
﹤0.01% 2273
2015
Q2
$262K Hold
10,200
﹤0.01% 2251
2015
Q1
$257K Hold
10,200
﹤0.01% 2258
2014
Q4
$242K Hold
10,200
﹤0.01% 2272
2014
Q3
$201K Sell
10,200
-29,861
-75% -$614K ﹤0.01% 2339
2014
Q2
$958K Sell
40,061
-136,488
-77% -$3.29M ﹤0.01% 1740
2014
Q1
$4.69M Sell
176,549
-363,270
-67% -$8.63M ﹤0.01% 1441
2013
Q4
$10.9M Sell
539,819
-858,866
-61% -$15.9M ﹤0.01% 1267
2013
Q3
$24.4M Buy
+1,398,685
New +$24.2M 0.01% 1027

Other funds holding GMED